Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors grow in those with the genetic condition neurofibromatosis type 1 (NF-1).

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […] ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...